| Primary |
| Sepsis |
12.9% |
| Bronchopneumonia |
11.4% |
| Meningitis Bacterial |
11.4% |
| Sinusitis |
11.4% |
| Brain Abscess |
4.3% |
| Bronchitis |
4.3% |
| Drug Use For Unknown Indication |
4.3% |
| Horner's Syndrome |
4.3% |
| Meningitis |
4.3% |
| Otitis Media |
4.3% |
| Analgesic Therapy |
2.9% |
| Cholecystitis |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Infection |
2.9% |
| Klebsiella Infection |
2.9% |
| Pain |
2.9% |
| Pleural Effusion |
2.9% |
| Pneumonia |
2.9% |
| Prophylaxis |
2.9% |
| Arrhythmia |
1.4% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
20.0% |
| Acute Generalised Exanthematous Pustulosis |
11.4% |
| Pancytopenia |
8.6% |
| Meningitis Aseptic |
5.7% |
| Rash |
5.7% |
| Rash Pruritic |
5.7% |
| Renal Tubular Necrosis |
5.7% |
| Anaphylactic Reaction |
2.9% |
| Blood Creatine Increased |
2.9% |
| Bone Marrow Failure |
2.9% |
| C-reactive Protein Increased |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Deafness |
2.9% |
| Hyperhidrosis |
2.9% |
| Hypotension |
2.9% |
| Inflammatory Bowel Disease |
2.9% |
| Intra-uterine Death |
2.9% |
| Lymphadenopathy |
2.9% |
| Lymphocytosis |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.2% |
| Product Used For Unknown Indication |
18.4% |
| Upper Respiratory Tract Infection |
9.2% |
| Pneumonia Mycoplasmal |
7.3% |
| Sepsis |
6.0% |
| Meningitis |
5.1% |
| Status Epilepticus |
4.1% |
| Lower Respiratory Tract Infection |
3.8% |
| Bronchopneumonia |
3.3% |
| Pneumonia |
3.3% |
| Endocarditis |
2.7% |
| Colitis Ulcerative |
2.4% |
| Febrile Convulsion |
2.4% |
| Asthma |
2.2% |
| Pneumocystis Jirovecii Pneumonia |
2.2% |
| Status Asthmaticus |
1.9% |
| Convulsion |
1.6% |
| Cytomegalovirus Infection |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Empyema |
1.6% |
|
| Toxic Epidermal Necrolysis |
18.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
10.9% |
| Thrombocytopenia |
9.4% |
| Agranulocytosis |
7.8% |
| Renal Failure Acute |
6.3% |
| Drug Ineffective |
4.7% |
| Vomiting |
4.7% |
| Acute Generalised Exanthematous Pustulosis |
3.1% |
| Aphasia |
3.1% |
| Brain Oedema |
3.1% |
| Coagulation Factor V Level Decreased |
3.1% |
| Hyperhidrosis |
3.1% |
| Pancreatitis Acute |
3.1% |
| Pyrexia |
3.1% |
| Rash |
3.1% |
| Renal Tubular Necrosis |
3.1% |
| Respiratory Failure |
3.1% |
| Stevens-johnson Syndrome |
3.1% |
| Adrenogenital Syndrome |
1.6% |
| Blepharospasm |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.6% |
| Drug Use For Unknown Indication |
13.0% |
| Prophylaxis |
9.1% |
| Hiv Infection |
6.9% |
| Renal Transplant |
6.4% |
| Pneumonia |
5.7% |
| Colitis Ulcerative |
4.6% |
| Infection |
3.5% |
| Asthma |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Liver Transplant |
3.2% |
| Prophylaxis Against Transplant Rejection |
3.0% |
| Meningitis Bacterial |
2.9% |
| Septic Shock |
2.7% |
| Bacterial Infection |
2.5% |
| Pyrexia |
2.4% |
| Diarrhoea |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Sepsis |
2.0% |
| Catheterisation Cardiac |
1.9% |
|
| Vomiting |
9.7% |
| Pyrexia |
8.8% |
| Sepsis |
7.1% |
| Wrong Technique In Drug Usage Process |
7.1% |
| Patent Ductus Arteriosus |
6.2% |
| Toxic Epidermal Necrolysis |
6.2% |
| Acute Respiratory Distress Syndrome |
5.3% |
| Renal Impairment |
5.3% |
| Septic Shock |
5.3% |
| Shock |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Pulmonary Haemorrhage |
3.5% |
| Rash Pustular |
3.5% |
| Renal Failure Acute |
3.5% |
| Thrombocytopenia |
3.5% |
| Wound Dehiscence |
3.5% |
| Colitis Ulcerative |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Lung Infection |
2.7% |
| Neonatal Disorder |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Myocardial Ischaemia |
33.3% |
|
| Strabismus |
66.7% |
| International Normalised Ratio Increased |
33.3% |
|
